Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Sentman

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironmentAmorette Barber, Agnieszka Rynda, Charles L Sentman
Cancer Research|November 17, 2007
Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathwaysTong Zhang, Amorette Barber, Charles L Sentman
Oncoimmunology|June 5, 2013
Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumorsPaul Spear, Amorette Barber, Charles L Sentman
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancerAmorette Barber, Tong Zhang, Charles L Sentman
Cancer Research|June 3, 2006
Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTong Zhang, Amorette Barber, Charles L Sentman
Journal of Cellular Physiology|May 11, 2016
How Chimeric Antigen Receptor Design Affects Adoptive T Cell TherapyAlbert T Gacerez, Benjamine Arellano, Charles L Sentman
Discovery Medicine|September 2, 2016
Regulatory T cell-based therapies for autoimmunityBenjamine Arellano, David J Graber, Charles L Sentman
Cancer Immunology, Immunotherapy : CII|December 13, 2006
NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivoMartin A Grundy, Tong Zhang, Charles L Sentman
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 16, 2007
NK cell function in the human female reproductive tractCharles L Sentman, Charles R Wira, Mikael Eriksson
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2012
An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivoTong Zhang, Ming-Ru Wu, Charles L Sentman
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironmentAmorette Barber, Agnieszka Rynda, Charles L Sentman
Cancer Research|November 17, 2007
Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathwaysTong Zhang, Amorette Barber, Charles L Sentman
Oncoimmunology|June 5, 2013
Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumorsPaul Spear, Amorette Barber, Charles L Sentman
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancerAmorette Barber, Tong Zhang, Charles L Sentman
Cancer Research|June 3, 2006
Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTong Zhang, Amorette Barber, Charles L Sentman
Journal of Cellular Physiology|May 11, 2016
How Chimeric Antigen Receptor Design Affects Adoptive T Cell TherapyAlbert T Gacerez, Benjamine Arellano, Charles L Sentman
Discovery Medicine|September 2, 2016
Regulatory T cell-based therapies for autoimmunityBenjamine Arellano, David J Graber, Charles L Sentman
Cancer Immunology, Immunotherapy : CII|December 13, 2006
NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivoMartin A Grundy, Tong Zhang, Charles L Sentman
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 16, 2007
NK cell function in the human female reproductive tractCharles L Sentman, Charles R Wira, Mikael Eriksson
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2012
An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivoTong Zhang, Ming-Ru Wu, Charles L Sentman
Pageof 8